Hollmann Travis J, Mueller-Ortiz Stacey L, Braun Michael C, Wetsel Rick A
Research Center for Immunology and Autoimmune Diseases, Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, University of Texas-Houston, TX77030, USA.
Mol Immunol. 2008 Apr;45(7):1907-15. doi: 10.1016/j.molimm.2007.10.037. Epub 2007 Dec 11.
The host response to intravascular, Gram-negative bacteria includes profound immunologic, hematologic and physiologic changes. Numerous host defense mechanisms are activated by Gram-negative bacteria, including the complement system. Activation of the complement system leads to cleavage of C5 with subsequent generation of the C5a anaphylatoxin peptide. C5a mediates potent, proinflammatory activities by binding to the C5a receptor (C5aR, CD88). In this study, we report the targeted disruption of the murine C5aR gene (C5aR-/- mice) and define the role of the C5aR in a model of Gram-negative bacteremia. Following an intravenous infusion of heat-killed Escherichia coli, the C5aR-/- mice were completely protected from the mortality suffered by their wild-type littermates (P<0.001). The C5aR-/- mice were also significantly (P=0.008) more resistant to mortality following an intravenous infusion of purified E. coli endotoxin compared to the wild-type littermates. In addition, the C5aR-/- mice were resistant to the thrombocytopenia and hemoconcentration observed in wild-type animals. Lethality in the wild-type mice was reversed by pre-treatment with either the histamine antagonist diphenhydramine or triprolidine. The wild-type littermates were also rescued following pre-treatment with the basophil and mast cell-stabilizing agent - cromolyn sodium. Collectively, these data demonstrate that not only is the absence of the C5aR protective in E. coli bacteremia, but that C5aR-dependent histamine release plays a major role in shock induced by Gram-negative septicemia. Moreover, they provide additional in vivo evidence that C3a and C5a have divergent biological functions in Gram-negative bacteremia and shock.
宿主对血管内革兰氏阴性菌的反应包括深刻的免疫、血液学和生理学变化。革兰氏阴性菌可激活众多宿主防御机制,包括补体系统。补体系统的激活导致C5裂解,随后生成C5a过敏毒素肽。C5a通过与C5a受体(C5aR,CD88)结合介导强大的促炎活性。在本研究中,我们报道了小鼠C5aR基因的靶向破坏(C5aR-/-小鼠),并确定了C5aR在革兰氏阴性菌血症模型中的作用。静脉注射热灭活的大肠杆菌后,C5aR-/-小鼠完全免受其野生型同窝小鼠所遭受的死亡(P<0.001)。与野生型同窝小鼠相比,静脉注射纯化的大肠杆菌内毒素后,C5aR-/-小鼠对死亡的抵抗力也显著增强(P=0.008)。此外,C5aR-/-小鼠对野生型动物中观察到的血小板减少和血液浓缩具有抵抗力。用组胺拮抗剂苯海拉明或曲普利啶预处理可逆转野生型小鼠的致死性。用嗜碱性粒细胞和肥大细胞稳定剂色甘酸钠预处理后,野生型同窝小鼠也得到了挽救。总体而言,这些数据表明,不仅缺乏C5aR在大肠杆菌菌血症中具有保护作用,而且C5aR依赖性组胺释放在革兰氏阴性败血症诱导的休克中起主要作用。此外,它们提供了额外的体内证据,表明C3a和C5a在革兰氏阴性菌血症和休克中具有不同的生物学功能。